Medical Stop Loss
Medical stop loss insurance protects employers with self-funded health plans against the risk of severe losses.
Cutting edge medical treatments often come at huge costs but with our Cell and Gene Therapy solutions, you can introduce your clients to these treatments at costs they can afford.
The rising costs of providing gene and cell therapies show no signs of letting up but the need for them is increasing all the time. Cell therapies can cost anywhere between $700,000 to $2m whereas gene therapies can have a cost ranging between $950,000 to $3.3m*.
To help your clients manage these costs, Tokio Marine HCC – Stop Loss Group has partnered with Emerging Therapy Solutions to provide a best-in-class service when, and how, your clients need it.
Don’t let costs limit the care you provide to your clients – let us take care of that for them.
* ETS - Cost of therapy is based on current known cost from publicly available information. NOTE: For full indications and label information, please visit manufacturer websites.
Medical stop loss insurance protects employers with self-funded health plans against the risk of severe losses.
Controls the severity of risk in a self-funded program through a stop loss captive.
Specifically designed and dedicated unit to meet the unique needs of Taft-Hartley union plans.
Fully insured option that coordinates with Medical Stop Loss to protect a self-funded plan from losses due to transplant exposures.